European Respiratory Journal (ERJ) - Archive
 |
|
Published in the English language, the ERJ features:
- cutting edge clinical and experimental work in the field of respiratory medicine
- original articles
- series
- editorials
- correspondence
- short reports and case studies
All of which pertain the highest quality from professionals on a worldwide scale. The ERJ is the most highly regarded, peer reviewed, Respiratory Journal in Europe. |
| January (Issue 1 Volume 35) |  |
| The European Respiratory Society, 1990-2010: a 20-year anniversary story of success
Siafakas N. M.
Eur Respir J 2010; 35: 1-2 |  |  | | | | | | | | | | | Does cannabis use predispose to chronic airflow obstruction?
Tashkin D. P.
Eur Respir J 2010; 35: 3-5 | | | | | | | | | | | | | Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension
Dorfmuller P., Montani D., Humbert M.
Eur Respir J 2010; 35: 6-8 | | | | | | | | | | | | | Combined pulmonary fibrosis and emphysema: a high-pressure situation
Munson J. C.
Eur Respir J 2010; 35: 9-11 | | | | | | | | | | | | | Is COPD in adulthood really so far removed from early development?
Shi W., Warburton D.
Eur Respir J 2010; 35: 12-13 | | | | | | | | | | | | | European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis
Johnson S. R., Cordier J. F., Lazor R., Cottin V., Costabel U., Harari S., Reynaud-Gaubert M., Boehler A., Brauner M., Popper H., Bonetti F., Kingswood C., the Review Panel of the ERS LAM Task Force
Eur Respir J 2010; 35: 14-26 | | | | | | | | | | | | | Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD
van Zyl Smit R. N., Pai M., Yew W. W., Leung C. C., Zumla A., Bateman E. D., Dheda K.
Eur Respir J 2010; 35: 27-33 | | |  | | | | | | | | | | Measuring airway dimensions during bronchoscopy using anatomical optical coherence tomography
Williamson J. P., Armstrong J. J., McLaughlin R. A., Noble P. B., West A. R., Becker S., Curatolo A., Noffsinger W. J., Mitchell H. W., Phillips M. J., Sampson D. D., Hillman D. R., Eastwood P. R.
Eur Respir J 2010; 35: 34-41 | | | | | | | | | | | | | Effects of cannabis on lung function: a population-based cohort study
Hancox R. J., Poulton R., Ely M., Welch D., Taylor D. R., McLachlan C. R., Greene J. M., Moffitt T. E., Caspi A., Sears M. R.
Eur Respir J 2010; 35: 42-47 | | | | | | | | | | | | | Monitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study
Chakir J., Loubaki L., Laviolette M., Milot J., Biardel S., Jayaram L., Pizzichini M., Pizzichini E., Hargreave F. E., Nair P., Boulet L-P.
Eur Respir J 2010; 35: 48-53 | | | | | | | | | | | | | Interaction of T-cell and antigen presenting cell co-stimulatory genes in childhood IgE
Bottema R. W. B., Postma D. S., Reijmerink N. E., Thijs C., Stelma F. F., Smit H. A., van Schayck C. P., Brunekreef B., Koppelman G. H., Kerkhof M.
Eur Respir J 2010; 35: 54-63 | | | | | | | | | | | | | Toll-like receptor 7 function is reduced in adolescents with asthma
Roponen M., Yerkovich S. T., Hollams E., Sly P. D., Holt P. G., Upham J. W.
Eur Respir J 2010; 35: 64-71 | | | | | | | | | | | | | Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD
Lehtimaki L., Kankaanranta H., Saarelainen S., Annila I., Aine T., Nieminen R., Moilanen E.
Eur Respir J 2010; 35: 72-78 | | | | | | | | | | | | | Is INTERdisciplinary COMmunity-based COPD management (INTERCOM) cost-effective?
Hoogendoorn M., van Wetering C. R., Schols A. M., Rutten-van Molken M. P. M. H.
Eur Respir J 2010; 35: 79-87 | | | | | | | | | | | | | Incidence and outcome of weaning from mechanical ventilation according to new categories
Funk G-C., Anders S., Breyer M-K., Burghuber O. C., Edelmann G., Heindl W., Hinterholzer G., Kohansal R., Schuster R., Schwarzmaier-D'Assie A., Valentin A., Hartl S.
Eur Respir J 2010; 35: 88-94 | | | | | | | | | | | | | Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension
Mathai S. C., Bueso M., Hummers L. K., Boyce D., Lechtzin N., Le Pavec J., Campo A., Champion H. C., Housten T., Forfia P. R., Zaiman A. L., Wigley F. M., Girgis R. E., Hassoun P. M.
Eur Respir J 2010; 35: 95-104 | | | | | | | | | | | | | Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome
Cottin V., Le Pavec J., Prevot G., Mal H., Humbert M., Simonneau G., Cordier J-F., GERM"O"P
Eur Respir J 2010; 35: 105-111 | | | | | | | | | | | | | Prognostic factors for lung function in systemic sclerosis: prospective study of 105 cases
Gilson M., Zerkak D., Wipff J., Dusser D., Dinh-Xuan A. T., Abitbol V., Chaussade S., Legmann P., Kahan A., Allanore Y.
Eur Respir J 2010; 35: 112-117 | | | | | | | | | | | | | Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1)
Raghu G., King T. E. Jr, Behr J., Brown K. K., du Bois R. M., Leconte I., Roux S., Swigris J.
Eur Respir J 2010; 35: 118-123 | | | | | | | | | | | | | Control of breathing in children with mild sleep apnoea: a 6-year follow-up study
Rice A., Costy-Bennett S., Goodwin J. L., Quan S. F., Fregosi R. F.
Eur Respir J 2010; 35: 124-131 | | | | | | | | | | | | | CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD
Machado M-C. L., Vollmer W. M., Togeiro S. M., Bilderback A. L., Oliveira M-V. C., Leitao F. S., Queiroga F. Jr, Lorenzi-Filho G., Krishnan J. A.
Eur Respir J 2010; 35: 132-137 | | | | | | | | | | | | | A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea
Lam J. C. M., Lam B., Yao T. J., Lai A. Y. K., Ooi C. G., Tam S., Lam K. S. L., Ip M. S. M.
Eur Respir J 2010; 35: 138-145 | | | | | | | | | | | | | Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes
Calabro E., Randi G., La Vecchia C., Sverzellati N., Marchiano A., Villani M., Zompatori M., Cassandro R., Harari S., Pastorino U.
Eur Respir J 2010; 35: 146-151 | | | | | | | | | | | | | Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer
Wright C. M., Larsen J. E., Colosimo M. L., Barr J. J., Chen L., McLachlan R. E., Yang I. A., Bowman R. V., Fong K. M.
Eur Respir J 2010; 35: 152-159 | | | | | | | | | | | | | Interleukin-8 activates coagulation and correlates with survival after talc pleurodesis
Montes-Worboys A., Rodriguez-Portal J. A., Arellano-Orden E., Digon-Pereiras J., Rodriguez-Panadero F.
Eur Respir J 2010; 35: 160-166 | | | | | | | | | | | | | The role of chemokine receptors in acute lung allograft rejection
Geleff S., Draganovici D., Jaksch P., Segerer S.
Eur Respir J 2010; 35: 167-175 | | | | | | | | | | | | | Bleomycin induces pleural and subpleural fibrosis in the presence of carbon particles
Decologne N., Wettstein G., Kolb M., Margetts P., Garrido C., Camus P., Bonniaud P.
Eur Respir J 2010; 35: 176-185 | | | | | | | | | | | | | Lung-specific inactivation of CCAAT/enhancer binding protein α causes a pathological pattern characteristic of COPD
Didon L., Roos A. B., Elmberger G. P., Gonzalez F. J., Nord M.
Eur Respir J 2010; 35: 186-197 | | | | | | | | | | | | | What lessons have been learnt from animal models of MRSA in the lung?
Martinez-Olondris P., Rigol M., Torres A.
Eur Respir J 2010; 35: 198-201 | | | | | | | | | | | | | Treatment of extensive-stage small cell lung carcinoma: current status and future prospects
Demedts I. K., Vermaelen K. Y., van Meerbeeck J. P.
Eur Respir J 2010; 35: 202-215 | | | | | | | | | | | | | An unusual cause of blindness
Seville R. A., Murchison J., Riha R. L.
Eur Respir J 2010; 35: 216-217 | | | | | | | | | | | | | Culture result of smear-positive sputum samples after 2 months of antituberculous treatment
Lim C-S., Lee C-H., Chien Y-J., Wang J-Y., Lee L-N., Yu C-J., Yang P-C., the TAMI group
Eur Respir J 2010; 35: 218-220 | | | | | | | | | | | | | A complication of peroral bronchoscopy
Thompson A. A. R., Raistrick C. S., Pirzada O. M., Anderson P. B.
Eur Respir J 2010; 35: 221-222 | | | | | | | | | | | | | Pulmonary arterial hypertension in systemic sclerosis: a distinctive endotheliopathy?
Orfanos S. E., Langleben D.
Eur Respir J 2010; 35: 223-224 | | | | | | | | | | | | | Nonthrombotic pulmonary embolism
Vinatier I., Rivaud E., Tcherakian C., Bisson A., Goudot B., Couderc L. J.
Eur Respir J 2010; 35: 224 | | | | | | | | | | | | | From the authors:
Song Y., Li X., Du X.
Eur Respir J 2010; 35: 225-226 | | | | | | | | | | | | | To the Editors:
Brain J. D., Kreyling W., Gehr P.
Eur Respir J 2010; 35: 226-227 | | | | | | | | | | | | | From the Editors:
The European Respiratory Journal Editors
Eur Respir J 2010; 35: 227 | | | | | | | | | | | | | Medicines for children in Europe: from proposals to practicalities
Bush A., Zach M.
Eur Respir J 2010; 35: 228-229 | | | | | | | | | | | |
|
|
WHAT YOU CAN FIND HERE  |
 |
Full text journal article |
 |
PDF journal article |
 |
Journal article abstract |
|
|